Biodesix, Inc. (BDSX)
USD 1.34
(-3.6%)
USD 1.34
(-3.6%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -52.14 Million USD | 35.13% |
| 2022 | -80.38 Million USD | -80.73% |
| 2021 | -44.48 Million USD | -21.95% |
| 2020 | -36.47 Million USD | -16.32% |
| 2019 | -31.35 Million USD | -19.83% |
| 2018 | -26.16 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -10.8 Million USD | 20.61% |
| 2024 Q1 | -13.61 Million USD | -48.97% |
| 2024 Q3 | -10.25 Million USD | 5.09% |
| 2023 Q2 | -13.35 Million USD | 21.97% |
| 2023 Q1 | -17.11 Million USD | 36.1% |
| 2023 FY | -52.14 Million USD | 35.13% |
| 2023 Q4 | -9.13 Million USD | 16.53% |
| 2023 Q3 | -10.94 Million USD | 18.02% |
| 2022 Q2 | -15.82 Million USD | 5.76% |
| 2022 FY | -80.38 Million USD | -80.73% |
| 2022 Q4 | -26.78 Million USD | -59.55% |
| 2022 Q1 | -16.79 Million USD | -26.43% |
| 2022 Q3 | -16.78 Million USD | -6.09% |
| 2021 Q3 | -11.51 Million USD | -0.98% |
| 2021 Q1 | -6.96 Million USD | -53.5% |
| 2021 FY | -44.48 Million USD | -21.95% |
| 2021 Q4 | -13.28 Million USD | -15.36% |
| 2021 Q2 | -11.4 Million USD | -63.8% |
| 2020 Q2 | -8.26 Million USD | 14.83% |
| 2020 FY | -36.47 Million USD | -16.32% |
| 2020 Q4 | -4.53 Million USD | 48.73% |
| 2020 Q3 | -8.84 Million USD | -7.0% |
| 2020 Q1 | -9.7 Million USD | -48.74% |
| 2019 Q2 | -7.29 Million USD | 0.0% |
| 2019 FY | -31.35 Million USD | -19.83% |
| 2019 Q4 | -6.52 Million USD | 32.04% |
| 2019 Q3 | -9.6 Million USD | -31.53% |
| 2019 Q1 | -7.29 Million USD | 0.0% |
| 2018 Q1 | -6.54 Million USD | 0.0% |
| 2018 Q2 | -6.54 Million USD | 0.0% |
| 2018 FY | -26.16 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 77.571% |
| Prenetics Global Limited | -62.72 Million USD | 16.864% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3268.605% |
| CareDx, Inc | -190.28 Million USD | 72.596% |
| Exact Sciences Corporation | -204.14 Million USD | 74.457% |
| Exagen Inc. | -23.68 Million USD | -120.127% |
| Inotiv, Inc. | -105.14 Million USD | 50.403% |
| Guardant Health, Inc. | -479.44 Million USD | 89.124% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -1883.459% |
| Precipio, Inc. | -5.85 Million USD | -790.928% |
| iSpecimen Inc. | -11.09 Million USD | -369.805% |
| Natera, Inc. | -434.8 Million USD | 88.007% |
| Aspira Women's Health Inc. | -16.69 Million USD | -212.439% |
| Standard BioTools Inc. | -74.65 Million USD | 30.152% |
| 23andMe Holding Co. | -666.7 Million USD | 92.179% |
| Castle Biosciences, Inc. | -57.46 Million USD | 9.258% |
| Personalis, Inc. | -108.29 Million USD | 51.849% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 41.065% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -424.235% |
| OpGen, Inc. | -32.66 Million USD | -59.622% |
| T2 Biosystems, Inc. | -50.07 Million USD | -4.132% |
| Myriad Genetics, Inc. | -112 Million USD | 53.441% |
| ICON Public Limited Company | 612.33 Million USD | 108.516% |
| NeoGenomics, Inc. | -87.96 Million USD | 40.722% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3268.605% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 106.171% |
| RadNet, Inc. | 3.04 Million USD | 1813.075% |
| MDxHealth SA | -43.1 Million USD | -20.988% |
| Psychemedics Corporation | -4.15 Million USD | -1155.32% |
| Illumina, Inc. | -1.16 Billion USD | 95.509% |
| Check-Cap Ltd. | -17.56 Million USD | -196.824% |
| Twist Bioscience Corporation | -208.72 Million USD | 75.017% |
| DarioHealth Corp. | -59.42 Million USD | 12.252% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 68.928% |
| Sera Prognostics, Inc. | -36.24 Million USD | -43.883% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -418.337% |
| OPKO Health, Inc. | -188.86 Million USD | 72.39% |
| Medpace Holdings, Inc. | 282.81 Million USD | 118.439% |
| Neogen Corporation | -9.42 Million USD | -453.508% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -413.412% |
| Prenetics Global Limited | -62.72 Million USD | 16.864% |
| Mainz Biomed B.V. | -26.29 Million USD | -98.306% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -556.998% |
| Trinity Biotech plc | -24.01 Million USD | -117.112% |
| Neuronetics, Inc. | -30.18 Million USD | -72.732% |
| Sotera Health Company | 51.37 Million USD | 201.499% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -556.998% |